MedTrace Logo

480 Biomedical Sinus Drug Depot

NCT02967731 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-08-25

No results posted yet for this study

Summary

This is a Phase I, exploratory safety study of the 480 Biomedical Mometasone Furoate Sinus Drug Depot in adult subjects with chronic sinusitis.

Conditions

  • Chronic Sinusitis

Interventions

DRUG

480 Mometasone Furoate Sinus Drug Depot

Management of Chronic Sinusitis

Sponsors & Collaborators

  • Lyra Therapeutics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2017-12-19
Completion
2018-05-18

Countries

  • Australia
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967731 on ClinicalTrials.gov